Evidence map›Paper›PMID 28551734›Full record

ReviewPaediatric drugs2017

Alopecia Areata: An Update on Treatment Options for Children.

Lauren Peloquin, Leslie Castelo-Soccio

Abstract readReview
PubMed Publisher
In one paragraph

Review in Paediatric drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Treatments for alopecia areata: a network meta-analysis.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Guideline
  3. Review
  4. Current issues in molecular biology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age.International journal of molecular sciences · 2019
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lauren PeloquinGeorgetown University School of Medicine, Washington, DC, USA.
Leslie Castelo-SoccioThe Children's Hospital of Philadelphia and The University of Pennsylvania, Perlman School of Medicine, 3401 Civic Center Blvd, Wood Center Room 3335, Philadelphia, PA, 19104, USA. castelosocciol@email.chop.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pediatric alopecia areata is a spectrum of autoimmune non-scarring alopecia in which some patients lose small patches of hair from their scalp but others lose more or all of the hair from the scalp and body, including eyebrows and eyelashes. Few studies have looked at therapies for this disorder in children, so much of the data are derived from adult literature and describe off-label use of medication. Generally, topical therapies consisting of topical steroids and topical irritating compounds/contact sensitizers are used. Systemic therapies that block the immune system, including Janus kinase (JAK) inhibitors, have also been used in this disease. This paper reviews the data on therapy for alopecia areata in pediatric patients.

Indexed as

Adrenal Cortex HormonesAlopecia AreataChildDrug Administration RoutesHumansOff-Label UseAdrenal Cortex Hormones

Identifiers

PMID28551734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.